Search
Menu
Deposition Sciences Inc. - Difficult Coatings - LB - 8/23

PhotOral

Facebook X LinkedIn Email
Boston-based life sciences startup PhotOral has licensed patented technology from Forsyth Institute of Cambridge, Mass., to develop an intraoral device that uses blue light for targeting and obliterating potentially harmful dental plaque microorganisms. The agreement enables PhotOral to commercialize Forsyth’s photomedicine portfolio, which addresses the $7 billion oral care market. Stamatis Astra, PhotOral’s founder and CEO, is raising funds to support prototype production, clinical trials and marketing operations. The company’s goal is to have its first intraoral light cleaning device available by late this year. The Harvard University-affiliated Forsyth Institute, a nonprofit research organization focused on oral, craniofacial and related biomedical sciences, will conduct PhotOral’s clinical trials.
Cognex Corp. - Smart Sensor 3-24 GIF MR

Published: February 2012
Glossary
phototherapy
Phototherapy is a medical treatment that involves the use of light to treat various conditions, particularly those related to the skin or mood disorders. There are different types of phototherapies, each tailored to address specific conditions: UV phototherapy: This form of phototherapy utilizes ultraviolet (UV) light to treat skin conditions such as psoriasis, eczema, vitiligo, and certain types of dermatitis. UV radiation can suppress the immune system and reduce inflammation, leading to...
Americasantimicrobial methodsBiophotonicsblue light technology for dental plaqueBusinessdental plaque microorganismsForsyth InstituteHarvard Universityintraoral deviceintraoral light cleaningMassachusettsMax GoodsonNikos Soukosperiodontal pathogensPhotOralphototherapyRapidScanStamatis Astra

We use cookies to improve user experience and analyze our website traffic as stated in our Privacy Policy. By using this website, you agree to the use of cookies unless you have disabled them.